Exocrine (merocrine)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd99/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd99/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd98/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd98/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd97/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd97/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd96/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd96/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd95/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd95/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd94/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd94/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd93/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd93/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd92/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd92/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd91/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd91/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd90/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd90/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd8f/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd8f/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd8e/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd8e/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd8d/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd8d/5be1eeb0df7f0b120034bd8b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1ef17df7f0b120034bd8c/5be1eeb0df7f0b120034bd8b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1ef17df7f0b120034bd8c/5be1eeb0df7f0b120034bd8b.png"}]